Hollow silica nanostructures let low-intensity ultrasound stimulate mouse brains for over nine weeks
Hong Kong Polytechnic University team reports hollow silica nanostructures that kept responding to ultrasound in mouse brains for over nine weeks. Earlier nanoparticle approaches lacked that durability. The evidence so far comes from mice.
Reality
- Evidence45
- Adoption
- Not scored
- Hype gap+20
- Incentives
- Not scored
- Confidence50
Microglia in a dish need the Parkinson's risk protein GPNMB to nibble toxic clumps off living neurons
Oxford researchers report human microglia nibble alpha-synuclein clumps off living dopamine neurons in stem-cell cultures, a process that needs GPNMB. A gene flagged by genome-wide studies now has a testable role in the brain's immune cells, though so far only in a dish.
Reality
- Evidence35
- Adoption
- Not scored
- Hype gap+40
- Incentives55
- Confidence40
Brain-stimulation timing decides cognition for GBA1 Parkinson's patients
Deep brain stimulation within 7 to 8 years of diagnosis preserved cognition in Parkinson's patients with a GBA1 mutation, a 10-center study of 343 found. The timing effect appeared only in carriers, pointing clinicians toward testing for the mutation before deciding when to operate.
Reality
- Evidence40
- Adoption
- Not scored
- Hype gap+45
- Incentives55
- Confidence35
Scans of 24 long COVID patients tie slowed movement and low motivation to depleted dopamine nerve endings
Canadian researchers scanning 24 people with long COVID found fewer dopamine nerve endings in the striatum, a shortfall tied to a quarter of symptom variance. The result gives drug trials a dopamine hypothesis to test, though the scan reads a protein marker that stands in for the neurons themselves.
Reality
- Evidence40
- Adoption
- Not scored
- Hype gap+30
- Incentives55
- Confidence45
Two RAB1 proteins bridge the adaptor OPTN to the vesicles that seed mitophagy membranes
Tokyo Metropolitan Institute of Medical Science researchers report that RAB1A and RAB1B, two of about 60 human RAB proteins, tie OPTN to ATG9A vesicles. The link helps set where the membrane around a damaged mitochondrion begins to form, and labs can now test that step directly.
Reality
- Evidence45
- Adoption
- Not scored
- Hype gap+10
- Incentives
- Not scored
- Confidence55
Belly button and nose odors differed by disease in a 24-person Fraunhofer pilot
Fraunhofer IIS researchers found swab odors from 24 people differed between healthy volunteers and those with Parkinson's, cognitive impairment or COVID-19. The team calls it a proof of concept, and a needle-free test would first have to hold up in larger, age-matched groups outside the lab.
Reality
- Evidence35
- Adoption
- Not scored
- Hype gap+10
- Incentives
- Not scored
- Confidence40
Cellular Intelligence has added Bob Langer and Yann LeCun to its scientific advisory board. The $62m to $70m it has raised now has to take STEM-PD, the cell therapy Novo Nordisk dropped, through Phase 2.
Reality
- Evidence45
- Adoption15
- Hype gap+40
- Incentives65
- Confidence55
University of Georgia researchers report the ten genes in Nature Communications and characterized six of them in detail. Knocking some of them out left planarians unable to make new dopamine neurons and slow to move.
Perspective Coverage
3 publishers
- Builder
- Builder 47%
- Operator
- Operator 35%
- Investor
- Investor 18%
Reality
- Evidence66
- Adoption
- Not scored
- Hype gap+24
- Incentives58
- Confidence62
Ariadne Bio aims a non-hallucinogenic 5-HT2A agonist at Parkinson's apathy
Palomar Labs' first spinout is built on a molecule whose parent compound was tested in the 1970s and documented not to be hallucinogenic. Apathy affects about 40% of people with Parkinson's, and no drug is approved for it.
Reality
- Evidence40
- Adoption8
- Hype gap+35
- Incentives82
- Confidence42
Journal of Voice study ties voice-disorder diagnoses to 58 percent higher dementia risk
The paper counted diagnoses clinicians wrote for patients aged 50 and over, and the risk more than doubled when hearing loss came with the voice disorder. Voice software was never in the study.
Reality
- Evidence55
- Adoption
- Not scored
- Hype gap+25
- Incentives40
- Confidence50